ValiRx Share News (VAL)
VAL Share
VAL Share
VAL Share
VAL Share
VAL
VAL Share
VAL Level 2
VAL Live
VAL Broker
VAL Directors
VAL Financial
VAL
VAL Short
VAL
Last checked at -
Fri, 24th Jul 2020 17:23
ValiRx PLC - clinical stage biotechnology company - Says broker option allowing current investors to participate in placing was fully subscribed and raised GBP300,700 through issue of 4.0 million shares at 7.5 pence each.
Current stock price: 7.88 pence
Year-to-date change: down 47%
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
ValiRx Competes GBP1.2 Million Placing To Fund VAL201 Trial Close-Out
Read more
(Sharecast News) - Clinical-stage biotechnology company ValiRx announced a conditional fundraise through the conditional issue of 18,069,467 new ordinary shares on Monday, to raise ?1.17m.
Read moreUK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO
Read more(Sharecast News) - Clinical-stage biotechnology company ValiRx has signed an agreement with an unnamed global Japanese pharmaceutical company to evaluate its therapeutic, VAL301, in order to contemplate a potential future license for its use in the treatment of endometriosis.
Read moreValiRx Signs Drug Transfer Agreement With Japanese Pharma Firm
Read moreUK WINNERS & LOSERS SUMMARY: RBS Rises Despite Profit Sinking
Read moreValiRx Confirms JV Talks For Non-Core Intellectual Property
Read moreUK EXECUTIVE CHANGE SUMMARY: Harvest Minerals CFO Leaves To Save Cost
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more(Sharecast News) - Clinical stage biotechnology company ValiRx announced on Wednesday that it has conditionally raised ?0.2m gross through the issue of 5,714,288 new ordinary shares at a post-reorganisation price of 3.5p each, with new investors.
Read moreValiRx Raises GBP200,000 To Improve "Extremely Weak" Capital Position
Read moreValiRx "Critically Short" Of Working Capital, In Funding Discussions
Read moreValiRx Still Faces Going Out Of Business; Proposes New Share Plan
Read moreValiRx Investors Seek Removal Of Directors Morris And Vainikka
Read moreValiRx's Future In Doubt As Investors Say No To Capital Reogranisation
Read more
Last checked at